611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Health Sciences
Resources
Basic InformationLatest News
Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryAHA News: Former NFL Players With Lots of Concussions May Have Higher Stroke RiskMore Years Playing Football, More Brain Lesions on MRI: StudyNew Insights Into What Might Drive Parkinson's DiseaseBrain's 'White Matter' Changes in People With AutismWearable Vibration Device May Ease Parkinson's TremorNeurologists' Group Issues New Treatment Guidelines for Early Parkinson'sGene Therapy Could Be Big Advance Against HemophiliaBlood Test Looks at Patients' Whole Genome to Spot Rare Inherited DiseasesSales of Unproven, Unapproved Stem Cell Therapies Are BoomingHow Bilingual Brains Shift Quickly Between LanguagesMouse Study Offers Hope for Gene Therapy Against Parkinson's DiseaseInsomnia Tied to Raised Risk of AneurysmAHA News: Could the Path to Better Brain Health Involve Better Mouth Care?More Americans Are Dying From Parkinson's Disease: StudyTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseResearchers Find Better Way to Fight Breast Cancer That Has Spread to BrainShape, Size of Brain Arteries May Predict Stroke RiskTracking Key Protein Helps Predict Outcomes in TBI PatientsSigns of Early Alzheimer's May Be Spotted in Brain StemCould Cholesterol Help Drive Alzheimer's Disease?Insights Into Genes Driving Epilepsy Could Help With TreatmentFewer American Adults Are Getting Malignant Brain TumorsLong-Term Outlook for Most With Serious Brain Injury Is Better Than ThoughtStroke Prevented His Speech, But Brain Implant Brought It BackWHO Calls for Global Registry of Human Genome EditingScientists Track Spirituality in the Human BrainNew Insights Into How Eating Disorders Alter the BrainGene Differences Could Have Black Patients Undergoing Unnecessary BiopsiesCRISPR Therapy Fights Rare Disease Where Protein Clogs OrgansNew Genetic Insights Into Cause of ALSDeep Brain Stimulation Therapy May Help Parkinson's Patients Long TermAmazon Tribe Could Hold Key to Health of Aging BrainsMan Blind for 40 Years Regains Some Sight Through Gene TherapyNew Insights Into Treating Mild Head Injuries'Ghosts and Guardian Angels': New Insights Into Parkinson's HallucinationsHigher Education Won't Help Preserve the Aging Brain: StudyScientists Create Embryos With Cells From Monkeys, Humans'Game of Thrones' Study Reveals the Power of Fiction on the MindScientists Create Human Tear Glands That Cry in the LabAHA News: How Grief Rewires the Brain and Can Affect Health – and What to Do About ItCould Taking a Swing at Golf Help Parkinson's Patients?Autopsy Study May Explain Why Some COVID Survivors Have 'Brain Fog'Gene Study Probes Origins of Addison's DiseaseCould a Common Prostate Drug Help Prevent Parkinson's?AHA News: Hormones Are Key in Brain Health Differences Between Men and WomenNerve Drug Might Curb Spinal Cord Damage, Mouse Study SuggestsIs There a 'Risk-Taking' Center in the Brain?AHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Can 2 Nutrients Lower Your Risk for Parkinson's?
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

More Americans Are Dying From Parkinson's Disease: Study

HealthDay News
by By Alan Mozes HealthDay Reporter
Updated: Oct 28th 2021

new article illustration

THURSDAY, Oct. 28, 2021 (HealthDay News) -- The number of Americans who are dying from Parkinson's disease has jumped by 63% in the past two decades, new research shows.

The fresh analysis also revealed that men face double the risk of dying from the progressive and incurable disease than women. A notably higher death rate was also seen among white people, as compared with peers of other racial/ethnic backgrounds.

"The message is straightforward," said study author Dr. Wei Bao. "This study showed that an increasing number of people died from Parkinson's disease during the past 20 years, and this cannot be simply explained by population aging."

Bao is an associate professor in the department of epidemiology at the University of Iowa's College of Public Health, in Iowa City. He and his colleagues published their findings online Oct. 27 in the journal Neurology.

According to the Michael J. Fox Foundation, Parkinson's affects roughly 1 million Americans and more than 6 million people around the world.

To get a handle on trends among Parkinson's patients, Bao and his colleagues analyzed data collected by the U.S. National Vital Statistics System.

The team found that nearly 480,000 Americans died of Parkinson's between 1999 and 2019.

During that time, the risk of dying from Parkinson's rose year after year by an average of 2.4%, with a significant increased risk seen among both men and women of all ages and ethnicities, and across both urban and rural locales, and in every state in the nation.

That steady rise translated into nearly nine out of every 100,000 Americans succumbing to Parkinson's by 2019. That figure is notably up from a little more than five Parkinson's deaths for every 100,000 Americans just 20 years earlier.

While risk went up across the board, men appeared to be much more vulnerable than women, the findings showed.

By 2019, the death rate among men was pegged at double that of women. One possible reason why: higher levels of estrogen in women may ultimately bolster motor control, the investigators said, and shield women from developing Parkinson's.

Death rates were also cited as being highest among white patients (9.7 per 100,000 people), followed by Hispanics (6.5 per 100,000) and Black people (4.7 per 100,000). The team cautioned, however, that some of that differential might reflect higher diagnosis rates among whites due to greater access to neurology care.

As to what might be driving up death rates overall, the study authors stressed that their research did not set out to identify cause, with Bao acknowledging that "the reason is not clear at present and warrants further investigation."

But the team theorized a number of possibilities. On the one hand, a higher death rate among Parkinson's patients may be at least partially linked to a rising risk for developing Parkinson's in the first place. And investigators pointed to a variety of reasons Parkinson's may be becoming more common, including worsening environmental factors such as elevated exposures to pesticides, heavy metals, air pollution and herbicides.

Improved accuracy on precise cause of death (as noted on death certificates) may also have played a role, the investigators added.

Still, James Beck, chief scientific officer for the Parkinson's Foundation, said the findings "are not surprising."

The foundation has also observed that the number of people with Parkinson's has risen, and "will continue to rise as the population ages, so an increase in mortality rates would be expected," he noted.

Beck said that improved diagnostics is what accounts for much of the rising death rates, as doctors become more adept at recognizing Parkinson's, "which would lead to higher rates of identifying PD [Parkinson's disease] as a cause of death."

Regardless, Dr. Rachel Dolhun, senior vice president of medical communications at the Michael J. Fox Foundation, suggested that while "more data is needed to better understand these trends," Parkinson's patients should not be discouraged by the numbers.

"If you're a person or family living with PD, I understand how a headline like this could be scary," she said. "But the bottom line is that these types of studies are helping us direct more resources and research so that we can learn more about the disease and its impact on the community, develop better treatments and a cure and, ultimately, prevent Parkinson's."

Meanwhile, "I often tell people — especially those newly diagnosed — that your Parkinson's is your Parkinson's. Your symptoms, how they change over time, and how they impact your life are all unique to you," Dolhun added. "The individualized nature of the disease can make it difficult to predict progression and symptoms in any one person."

So, she said, the goal is "to manage the disease and live as well as possible," through a combination of diet, exercise and good physician guidance, because "for many, Parkinson's doesn't significantly shorten lifespan."

More information

There's more on Parkinson's at the Michael J. Fox Foundation.

SOURCES: Wei Bao, MD, PhD, associate professor, department of epidemiology, College of Public Health, University of Iowa, Iowa City; James Beck, PhD, chief scientific officer, Parkinson's Foundation, Miami; Rachel Dolhun, MD, senior vice president, medical communications, Michael J. Fox Foundation, New York City; Neurology, Oct. 27, 2021, online